News
A University of Dundee spinout company has been named among the world’s most promising start-ups after being nominated for a prestigious global prize.
News
A University of Dundee spinout company has been named among the world’s most promising start-ups after being nominated for a prestigious global prize.
News
A University of Dundee spinout has announced a multi-million pound deal to develop first-in-class therapeutics that restore the body's natural disease suppression processes.
News
Parliamentarians from across the political spectrum today heard how University of Dundee research could help save millions of lives in low- and middle-income countries (LMICs)
News
A prestigious audience of policy makers, entrepreneurs and scientists from across the UK will hear about Dundee’s world-leading expertise in drug discovery at next month’s Braemar Summit.
News
Last month, our SLS Athena Swan committee hosted their first Summer Family BBQ at the University of Dundee Botanic Garden.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm.
News
The finalists for Converge 2020, Scotland’s leading academic company creation programme, have been announced with representation from the School included on the list with Dr Robyn Hickerson, Co-founder and Chief Scientific Officer of Ten Bio.
News
This week forty researchers completed a two-day workshop in Cryo Electron Microscopy (EM) held in the School.
News
A mixed audience of postdocs and PhD students gathered to hear from a panel of newly appointed PIs within SLS.
News
Academics Abroad which is a project designed to raise the profile of the University in key geographies.
News
Evotec invests in Exscientia to advance AI-driven drug discovery
News
A new diagnostic test developed from research at the Universities of Dundee and Cambridge has been launched with the aim of helping eliminate the disease known as African sleeping sickness.
News
Pre-clinical collaboration focused on up to 10 targets nominated by GSK